SCHEMBL185808

SCHEMBL185808

NC1CC1.O=C(O)NCc1ccc(Nc2ccc(Br)cc2C(F)(F)F)cn1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 11/20 0.39
KIT P10721 9/20 0.39
CNR2 P34972 1/20 0.37
DHODH Q02127 2/20 0.36
KDM1A O60341 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MPO P05164 1/20 0.34
OPRM1 P35372 1/20 0.34
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL14856648 0.97 FLT3 (0.38) FLT3KITCNR2DHODHKDM1A
SCHEMBL185476 0.90 KIT (0.40) FLT3KITCNR2DHODH
SCHEMBL185393 0.89 CNR2 (0.42) FLT3KITCNR2RAB9AKDM4E
Trifluoroacetic Acid SCHEMBL14856625 0.86 CNR2 (0.40) FLT3KITCNR2RAB9AKDM4E
SCHEMBL2807621 0.84 CNR2 (0.40) FLT3KITCNR2NPC1RAB9A
SCHEMBL2808542 0.83 CNR2 (0.41) FLT3KITCNR2NPC1RAB9A
Trifluoroacetic Acid SCHEMBL2813582 0.82 CNR2 (0.39) CNR2DHODHNPC1RAB9AMPO
SCHEMBL2805079 0.82 CNR2 (0.39) CNR2DHODHNPC1RAB9AMPO
SCHEMBL2808884 0.81 CNR2 (0.40) FLT3KITCNR2NPC1RAB9A
SCHEMBL13160090 0.81 MAPK10 (0.41) FLT3CNR2CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed